T&R Biofab Balance Sheet Health
Financial Health criteria checks 4/6
T&R Biofab has a total shareholder equity of ₩23.8B and total debt of ₩35.8B, which brings its debt-to-equity ratio to 150.4%. Its total assets and total liabilities are ₩79.0B and ₩55.2B respectively.
Key information
150.4%
Debt to equity ratio
₩35.77b
Debt
Interest coverage ratio | n/a |
Cash | ₩29.48b |
Equity | ₩23.78b |
Total liabilities | ₩55.23b |
Total assets | ₩79.01b |
Recent financial health updates
Recent updates
Is T&R Biofab (KOSDAQ:246710) Using Debt Sensibly?
Feb 26Do Insiders Own Lots Of Shares In T&R Biofab Co., Ltd. (KOSDAQ:246710)?
Mar 09Can You Imagine How T&R Biofab's (KOSDAQ:246710) Shareholders Feel About The 65% Share Price Increase?
Jan 12Do Institutions Own T&R Biofab Co., Ltd. (KOSDAQ:246710) Shares?
Nov 18Financial Position Analysis
Short Term Liabilities: A246710's short term assets (₩36.4B) do not cover its short term liabilities (₩37.6B).
Long Term Liabilities: A246710's short term assets (₩36.4B) exceed its long term liabilities (₩17.6B).
Debt to Equity History and Analysis
Debt Level: A246710's net debt to equity ratio (26.4%) is considered satisfactory.
Reducing Debt: A246710's debt to equity ratio has increased from 0% to 150.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A246710 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A246710 has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 26.8% each year.